222 related articles for article (PubMed ID: 17984930)
21. Expression of genes related to corticotropin production and glucocorticoid feedback in corticotroph adenomas of dogs with Cushing's disease.
Teshima T; Hara Y; Takekoshi S; Teramoto A; Osamura RY; Tagawa M
Domest Anim Endocrinol; 2009 Jan; 36(1):3-12. PubMed ID: 18818046
[TBL] [Abstract][Full Text] [Related]
22. [Cushing's syndrome. II. New forms of treatment].
van Aken MO; Feelders RA; van der Lely AJ; Romijn JA; Lamberts SW; de Herder WW
Ned Tijdschr Geneeskd; 2006 Oct; 150(43):2365-9. PubMed ID: 17100127
[TBL] [Abstract][Full Text] [Related]
23. Effect of SOM230 (pasireotide) on corticotropic cells: action in dogs with Cushing's disease.
Castillo V; Theodoropoulou M; Stalla J; Gallelli MF; Cabrera-Blatter MF; Haedo MR; Labeur M; Schmid HA; Stalla GK; Arzt E
Neuroendocrinology; 2011; 94(2):124-36. PubMed ID: 21525729
[TBL] [Abstract][Full Text] [Related]
24. [Response of thyrotropinoma to somatostatin analogues: report of a case].
García Lafuente N; Berná Gascón MT; Pujalte López E; Falcó Jover G; Domínguez Escribano JR
An Med Interna; 2001 Dec; 18(12):663. PubMed ID: 11852512
[No Abstract] [Full Text] [Related]
25. New SRIF analogs in the control of human pituitary adenomas: perspectives.
Jaquet P; Saveanu A; Barlier A
J Endocrinol Invest; 2005; 28(5 Suppl):14-8. PubMed ID: 16114269
[TBL] [Abstract][Full Text] [Related]
26. Glucocorticoid Receptor Antagonism Upregulates Somatostatin Receptor Subtype 2 Expression in ACTH-Producing Neuroendocrine Tumors: New Insight Based on the Selective Glucocorticoid Receptor Modulator Relacorilant.
Pivonello R; Munster PN; Terzolo M; Ferrigno R; Simeoli C; Puglisi S; Bali U; Moraitis AG
Front Endocrinol (Lausanne); 2021; 12():793262. PubMed ID: 35058882
[TBL] [Abstract][Full Text] [Related]
27. Genetic abnormalities of somatostatin receptors in pituitary tumors.
Lania A; Mantovani G; Spada A
Mol Cell Endocrinol; 2008 May; 286(1-2):180-6. PubMed ID: 17913341
[TBL] [Abstract][Full Text] [Related]
28. Synthetic MIF has no effect on beta-MSH and ACTH hypersecretion in Nelson's syndrome.
Donnadieu M; Laurent MF; Luton JP; Bricaire H; Girard F; Binoux M
J Clin Endocrinol Metab; 1976 Jun; 42(6):1145-8. PubMed ID: 6486
[TBL] [Abstract][Full Text] [Related]
29. "Silent"corticotropinoma.
Pawlikowski M; Kunert-Radek J; Radek M
Neuro Endocrinol Lett; 2008 Jun; 29(3):347-50. PubMed ID: 18580839
[TBL] [Abstract][Full Text] [Related]
30. Pneumocystis carinii pneumonia associated with a rapid reduction of cortisol level in a patient with ectopic ACTH syndrome treated by octreotide and ketoconazole.
Kim DS; Park SK; Choi WH; Kim TW; Choi YY; Jeon SC; Ryu JS
Exp Clin Endocrinol Diabetes; 2000; 108(2):146-50. PubMed ID: 10826524
[TBL] [Abstract][Full Text] [Related]
31. Ectopic Cushing's syndrome due to concurrent corticotropin-releasing hormone (CRH) and adrenocorticotropic hormone (ACTH) secreted by malignant gastrinoma.
Park SY; Rhee Y; Youn JC; Park YN; Lee S; Kim DM; Song SY; Lim SK
Exp Clin Endocrinol Diabetes; 2007 Jan; 115(1):13-6. PubMed ID: 17286228
[TBL] [Abstract][Full Text] [Related]
32. Octreotide and ketoconazole for persistent ectopic ACTH Cushing's disease due to mediastinal carcinoid.
Parthiban A; Sundaram DS; Reddy DJ; Girinath MR; Prabhakaran R; Chidambaranathan N
J Assoc Physicians India; 1995 Feb; 43(2):140. PubMed ID: 9282686
[No Abstract] [Full Text] [Related]
33. Plasma galanin, vasopressin, and oxytocin in patients with Addison's disease.
Grenbäck E; Hulting AL; Bucht E; Petersson M
Horm Metab Res; 2007 Aug; 39(8):589-95. PubMed ID: 17712724
[TBL] [Abstract][Full Text] [Related]
34. Long-term basal and dynamic evaluation of hypothalamic-pituitary-adrenal (HPA) axis in acromegalic patients.
Ronchi CL; Ferrante E; Rizzo E; Giavoli C; Verrua E; Bergamaschi S; Lania AG; Beck-Peccoz P; Spada A
Clin Endocrinol (Oxf); 2008 Oct; 69(4):608-12. PubMed ID: 18410544
[TBL] [Abstract][Full Text] [Related]
35. Protein expression of somatostatin receptor 2, somatostatin receptor 5 and dopamine D2 receptor in normal pituitary gland and ACTH-secreting pituitary adenoma in dogs.
Sato A; Hara Y
Res Vet Sci; 2018 Aug; 119():61-66. PubMed ID: 29864631
[TBL] [Abstract][Full Text] [Related]
36. Potential indications for somatostatin analogs in Cushing's syndrome.
Arnaldi G; Polenta B; Cardinaletti M; Boscaro M
J Endocrinol Invest; 2005; 28(11 Suppl International):106-10. PubMed ID: 16625858
[TBL] [Abstract][Full Text] [Related]
37. Hormonal secretion and quality of life in Nelson syndrome and Cushing disease after long acting repeatable octreotide: a short series and update.
Arregger AL; Cardoso EM; Sandoval OB; Monardes Tumilasci EG; Sanchez R; Contreras LN
Am J Ther; 2014; 21(4):e110-6. PubMed ID: 22820717
[TBL] [Abstract][Full Text] [Related]
38. Pharyngeal pituitary non-functioning adenoma with normal intra-sellar gland: massive tumor shrinkage on octreotide therapy.
Pugnale N; Waridel F; Bouzourène H; Boubaker A; Pugnale M; Gaillard RC; Gomez F
Eur J Endocrinol; 2003 Mar; 148(3):357-64. PubMed ID: 12611618
[TBL] [Abstract][Full Text] [Related]
39. Effects of selective somatostatin analogs and cortistatin on cell viability in cultured human non-functioning pituitary adenomas.
Padova H; Rubinfeld H; Hadani M; Cohen ZR; Nass D; Taylor JE; Culler MD; Shimon I
Mol Cell Endocrinol; 2008 May; 286(1-2):214-8. PubMed ID: 18276067
[TBL] [Abstract][Full Text] [Related]
40. Subclinical Cushing syndrome associated with an empty sella turcica.
Yoshida M; Miyata M; Ueda H; Oiso Y
Intern Med; 2014; 53(6):637-8. PubMed ID: 24633039
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
